On Monday, the 23rd of March 2020, the Detroit-based United States’ No. 1 automotive industry giant General Motors Co. had issued a statement saying that the carmaker had been studying the possibility of manufacturing ventilators under its JV with the Seattle-based bio-pharmaceutical company Ventec Life Systems at its Kokomo, Indiana plant in order to battle past the coronavirus outbreak in the United States which had killed 117 US nationals over the past 24 hours, while 9,456 newer coronavirus cases were detected in several states of the World’s No.
1 economy, which a slew of Wall St. analysts suggested had been at the brink of entering into a protracted financial depression. Aside from that, according to an email sent by the suppliers to the GM Vice President of global purchasing, Shilpan Amin, seen by a press agency reporter, the United States’ largest automaker had arranged 95 per cent of the toolkits required to build the ventilators thus far and had been on the lookout for remaining 37 necessary parts, while at least five people familiar with the issue had confirmed on condition of anonymity that the General Motors Co.-Ventec Life Systems JV was looking to manufacture up to 200,000 ventilators.
On top of that, as the US President Donald Trump had also given a go-ahead signal to e-vehicle industry pioneer Tesla Inc. alongside United States’ No. 2 carmaker Ford Motor Co. to start manufacturing ventilators on Sunday (March 22nd), a General Motors Co.
spokesman Dan Flores said in an emailed statement on Monday (March 23rd), “Ventec Life Systems and General Motors have been working around the clock to implement plans to build more critical care ventilators. With GM’s support, Ventec is now planning exponentially higher ventilator production as fast as possible.
As part of those efforts, GM is exploring the feasibility to build ventilators for Ventec at a GM facility in Kokomo, Indiana. ”